You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
小智港股覆盤 | 4月21日

今日,港股三大指數集體下跌。截止收盤,恆生指數跌1.25%,報20682點。國企指數跌1.92%,報6962點。恆生科技指數大跌3.48%,報3990點。市場約428只個股上漲,1278只個股下跌。成交額突破1200.86億港幣,和昨天同期相比增長22.49%。南下資金淨流出22.26億港幣。

領跌板塊

盤面上,電力板塊活躍。電能實業、中電控股等多股漲超1%

板塊行情

公路與鐵路板塊走高

板塊行情

CRO板塊全線走低。藥明生物跌超6%;方達控股跌超5%;奧星生命科技跌超4%;藥明康德、金斯瑞生物科技等多股跌超3%。美銀證券維持中遠海能“買入”評級,藥明生物獲機構看至101.11港元。

板塊行情

互聯網醫療板塊暴跌。阿裏健康跌超6%;平安好醫生跌超4%;醫脈通、醫渡科技等多股跌超3%;中智全球跌超2%。平安好醫生4月19日耗資533.18萬港元回購25萬股;高盛降醫渡科技目標價至40元,評級「買入」。

板塊行情

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account